Skip to main content
Clinical Trials/NCT04917159
NCT04917159
Completed
Not Applicable

Effectiveness of Acceptance and Commitment Therapy on the Health-related Quality of Life in Patients With Chronic Heart Failure and Their Family Caregivers: A Randomized Controlled Trial

The Hong Kong Polytechnic University1 site in 1 country362 target enrollmentJune 10, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Heart Failure
Sponsor
The Hong Kong Polytechnic University
Enrollment
362
Locations
1
Primary Endpoint
Change from baseline in patients' CHF specific health-related quality of life at immediately post-intervention
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study is to examine whether group-based Acceptance and Commitment Therapy in the patient-caregiver dyads with Chronic Heart Failure is effective in improving dyadic health-related quality of life, dyadic psychological symptoms, caregiver burden, the rate of patient's readmission, and patient's self-care behavior in comparison with those dyads receiving health education over three-month post intervention.

Detailed Description

Chronic heart failure (CHF) is a complex progressive debilitating illness characterized by high morbidity and mortality with unpredictable course and frequent hospital readmissions. Patients with CHF are often old with comorbid impaired psychosocial functioning, and worse health-related quality of life (HRQoL), which generate unavoidable increased dependence on their family caregivers at home. The family caregivers often bear physical and psychological challenges with declined HRQoL, maintaining interdependent relationships with their care recipient when participating in CHF self-management. Dyadic interventions delivered to the patients along with their family caregivers are successful to facilitate patients' self-management to reduce patients' hospital readmission rates and improve HRQoL for both patients and their caregivers post-discharge in the context of chronic disease management. However, little attention has been paid to this vulnerable group. It is noteworthy that a transdiagnostic psychological approach, Acceptance and Commitment Therapy (ACT), aiming to promote psychological flexibility, has demonstrated an ability to break through the psychological barriers to meaningful living among clinical and non-clinical populations. Existing evidence shows promising improvements of ACT on HRQoL in both patients with chronic illness and the family caregivers of the patients with childhood illness. Such evidence implies that ACT in the patient-caregiver dyads may be beneficial for HRQoL and other health outcomes for both patients with CHF and their family caregivers. However, little has been done to address these concerns in mainland China. A pilot testing was to evaluate the feasibility of recruiting participants at the clinical setting and the acceptability of group-based ACT to patient-caregiver dyads with CHF. Then, a pragmatic, single-center, two-arm, parallel (in 1:1 ratio) randomized controlled trial (RCT) will be performed to examine the effects of acceptance and commitment therapy in patient-caregiver dyads with CHF. Eligible patient-caregiver dyads will be randomly assigned to either the intervention group or the control group. Assessments will be conducted before the intervention, immediately post-intervention, and 3-month post-intervention by blind outcome assessors. The ACT intervention will be delivered by two facilitators and continually supervised by an experienced ACT researcher.

Registry
clinicaltrials.gov
Start Date
June 10, 2022
End Date
September 14, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years or older
  • a confirmed diagnosis of Chronic Heart Failure (CHF) according to international guidelines
  • with New York Heart Association (NYHA) functional classification I to III
  • has been hospitalized in the past one year
  • able to nominate a primary family caregiver (if two or more family members where the primary caregivers of the patient, the one who had the highest average contact hours with the patient)
  • can understand and communicate in Chinese
  • can access Tencent VooV Meeting via smartphone for attending the intervention

Exclusion Criteria

  • has a documented medical history of psychiatric illness, dementia, and life-threatening, such as end-stage renal failure, severe pulmonary disease and respiratory disease
  • has cognitive impairment evaluated with a score of 0-2 on the Mini-Cog scale
  • living in a nursing home
  • Inclusion Criteria:
  • 18 years or older
  • can understand and communicate in Chinese
  • have been providing care to the patient for more than 14 hours per week for at least three consecutive months
  • can access Tencent VooV Meeting via smartphone for attending the intervention
  • Exclusion Criteria:
  • paid caregivers

Outcomes

Primary Outcomes

Change from baseline in patients' CHF specific health-related quality of life at immediately post-intervention

Time Frame: Baseline and post-intervention immediately

The short-form Kansas City Cardiomyopathy Questionnaire (KCCQ-12) will be used for patients. KCCQ-12 is a 12-item instrument with a score of 0-100, a lower score indicates a poorer quality of life.

Change from baseline in patients' generic health-related quality of life at immediately post-intervention

Time Frame: Baseline and post-intervention immediately

The five-dimensional descriptive system of the EuroQol Group 5-Dimension questionnaire (EQ-5D-5L) will be used to evaluate generic health-related quality of life for patients. The scores range from less than 0 to 1.0, with higher scores representing higher health utility.

Change from baseline in patients' CHF specific health-related quality of life at 3-month post-intervention

Time Frame: Baseline and three-month post-intervention

The short-form Kansas City Cardiomyopathy Questionnaire (KCCQ-12) will be used for patients. KCCQ-12 is a 12-item instrument with a score of 0-100, a lower score indicates a poorer quality of life.

Change from baseline in patients' generic health-related quality of life at three-month post-intervention

Time Frame: Baseline and three-month post-intervention

The five-dimensional descriptive system of the EuroQol Group 5-Dimension questionnaire (EQ-5D-5L) will be used to evaluate generic health-related quality of life for patients. The scores range from less than 0 to 1.0, with higher scores representing higher health utility.

Change from baseline in caregivers' health-related quality of life at immediately post-intervention

Time Frame: Baseline and post-intervention immediately

The five-dimensional descriptive system of the EuroQol Group 5-Dimension questionnaire (EQ-5D-5L) will be used to evaluate generic health-related quality of life for caregivers. The scores range from less than 0 to 1.0, with higher scores representing higher health utility.

Change from baseline in caregivers' health-related quality of life at three-month post-intervention

Time Frame: Baseline and three-month post-intervention

The five-dimensional descriptive system of the EuroQol Group 5-Dimension questionnaire (EQ-5D-5L) will be used to evaluate generic health-related quality of life for caregivers. The scores range from less than 0 to 1.0, with higher scores representing higher health utility.

Secondary Outcomes

  • Change from baseline in patients' unscheduled health service visits due to heart-related problems at three-month post-intervention(Baseline and three-month post-intervention)
  • Change from baseline in patients' CHF self-care behavior at immediately post-intervention(Baseline and three-month post-intervention)
  • Change from baseline in patients' smoking status at immediately post-intervention(Baseline and post-intervention immediately)
  • Change from baseline in patients' smoking status at three-month post-intervention(Baseline and three-month post-intervention)
  • Change from baseline in patients' alcohol status at three-month post-intervention(Baseline and three-month post-intervention)
  • Change from baseline in caregivers' perceived care burden at three-month post-intervention(Baseline and three-month post-intervention)
  • Change from baseline in participants' depressive symptoms at immediately post-intervention(Baseline and post-intervention immediately)
  • Change from baseline in patients' alcohol status at immediately post-intervention(Baseline and post-intervention immediately)
  • Change from baseline in caregivers' perceived care burden at immediately post-intervention(Baseline and post-intervention immediately)
  • Change from baseline in patients' unscheduled health service visits due to heart-related problems at immediately post-intervention(Baseline and post-intervention immediately)
  • Change from baseline in participants' anxiety symptoms at immediately post-intervention(Baseline and post-intervention immediately)
  • Change from baseline in participants' anxiety symptoms at three-month post-intervention(Baseline and three-month post-intervention)
  • Change from baseline in participants' depressive symptoms at three-month post-intervention(Baseline and three-month post-intervention)
  • Change from baseline in participants' perspective taking at immediately post-intervention(Baseline and post-intervention immediately)
  • Change from baseline in participants' perspective taking at three-month post-intervention(Baseline and three-month post-intervention)
  • Change from baseline in participants' psychological flexibility at immediately post-intervention(Baseline and post-intervention immediately)
  • Change from baseline in participants' psychological flexibility at three-month post-intervention(Baseline and three-month post-intervention)
  • Change from baseline in participants' relationship functioning at immediately post-intervention(Baseline and post-intervention immediately)
  • Change from baseline in participants' relationship functioning at three-month post-intervention(Baseline and three-month post-intervention)
  • Change from baseline in participants' generic health-related quality of life at immediately post-intervention(Baseline and post-intervention immediately)
  • Change from baseline in participants' generic health-related quality of life at three-month post-intervention(Baseline and three-month post-intervention)
  • Change from baseline in participants' self-compassion at immediately post-intervention(Baseline and post-intervention immediately)
  • Change from baseline in participants' self-compassion at three-month post-intervention(Baseline and three-month post-intervention)

Study Sites (1)

Loading locations...

Similar Trials